HDAC7 and B-cell non-Hodgkin lymphoma: Taken together, our findings suggest that HDAC7 expression may exert an anti-oncogenic activity in particular types of B-cell malignancies and that its deregulation may contribute to the pathogenesis of B-ALL and B-cell lymphoma.